Company Filing History:
2 out of 8,693 
2 out of 90 
1 out of 5 Years Active: 1979-1992
Title: Edward A Nodiff: Innovator in Malaria Treatment
Introduction
Edward A Nodiff is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of malaria. With a total of 6 patents to his name, Nodiff's work has had a profound impact on malarial chemotherapy.
Latest Patents
Nodiff's latest patents include 5-(phenylalkoxy)primaquine and 5-[(heterocycle)alkoxy]primaquine. These compounds have demonstrated improvements in the treatment of malaria. The 5-[(aryl)alkoxy]primaquine compounds are effective in combating malarial parasites present in both the blood and tissues of the host. Notably, these compounds are at least as effective as prior art 5-alkoxy primaquine compounds but exhibit lower toxicity at higher dosage ranges. The 5-[(heterocycle)alkoxy]primaquine compounds also show reduced toxicity compared to primaquine in blood schizonticidal studies, while maintaining comparable efficacy to the 5-arylalkoxy primaquine compounds.
Career Highlights
Throughout his career, Nodiff has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and Calspan Corporation. His innovative work has been recognized and utilized in various medical applications.
Collaborations
Nodiff has collaborated with notable individuals in his field, including Andrew J Saggiomo and Eugene H Chen. These partnerships have contributed to the advancement of his research and the development of effective treatments for malaria.
Conclusion
Edward A Nodiff's contributions to malaria treatment through his innovative patents highlight his importance in the field of medical research. His work continues to influence the development of safer and more effective therapies for combating malaria.